Floatz logo

ct125a cells

Follicular Lymphoma (FL)

Huazhong University of Science and TechnologyCell therapyEarly Phase 1Dormant
C
38/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
81/ 100

Competitive context

210 Active assets in the Follicular Lymphoma (FL) cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 2/3BBB
Romidepsin
City of Hope Medical Center
Phase 2BBB
Recombinant Human Hyaluronidase
National Cancer Institute (NCI)
Phase 3BBB
VINCRISTINE SULFATE
National Cancer Institute (NCI)
Phase 3BBB
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 2/3BBB

View all 50 →

Same molecule, other indications

ct125a cells is also rated in:

hematopoietic and lymphoid system neoplasmDormant
C
Indicative ·
39 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
C
Indicative ·
39 / 100
View asset →
mature T-cell and NK-cell non-Hodgkin lymphomaDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →